Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients? - Suppr | 超能文献

Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?

作者信息

Scott J S, Boyle G J, Daubeney P E, Miller S A, Law Y, Pigula F, Griffith B P, Webber S A

机构信息

Department of Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania, USA.

出版信息

Transplant Proc. 1999 Feb-Mar;31(1-2):82-3. doi: 10.1016/s0041-1345(98)01447-x.

DOI:10.1016/s0041-1345(98)01447-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?

Transplant Proc. 1999 Feb-Mar;31(1-2):82-3. doi: 10.1016/s0041-1345(98)01447-x.

2

Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.一名6岁肾移植受者在肾移植5年后他克莫司相关肥厚性梗阻性心肌病的逆转。

Pediatr Transplant. 2005 Feb;9(1):117-21. doi: 10.1111/j.1399-3046.2005.00260.x.

3

Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.成人心脏移植患者中环孢素相关肥厚型心肌病。

Chin Med J (Engl). 2012 Apr;125(7):1352-4.

4

Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.一名接受FK506治疗的肝移植患者出现全身性水肿和肥厚型心肌病：改用新山地明后症状缓解。

Transplant Proc. 1996 Aug;28(4):2250-1.

5

Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy.西罗莫司在小儿胃肠移植中的应用：西罗莫司用于患有他克莫司相关心肌病的小儿移植患者。

Pediatr Transplant. 2000 Feb;4(1):45-9. doi: 10.1034/j.1399-3046.2000.00083.x.

6

Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.肝移植受者他克莫司相关性肥厚型心肌病。

Arch Iran Med. 2010 Mar;13(2):116-9.

7

Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.原位肝移植术后儿童肥厚型心肌病的超声心动图表现

Pediatr Transplant. 2001 Jun;5(3):187-91. doi: 10.1034/j.1399-3046.2001.00052.x.

8

Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.一名小儿肝移植受者在转换为雷帕霉素治疗后，他克莫司相关的肥厚型心肌病得到逆转。

Pediatr Transplant. 2007 May;11(3):319-23. doi: 10.1111/j.1399-3046.2006.00633.x.

9

Lack of tacrolimus-induced cardiomyopathy.无他克莫司诱发的心肌病。

Ann Pharmacother. 2001 Sep;35(9):985-9. doi: 10.1345/aph.10299.

10

New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的小儿胸器官受者新发糖尿病

J Heart Lung Transplant. 1997 Mar;16(3):275-82.

引用本文的文献

1

Reversible Tacrolimus-Induced Dilated Hypokinetic Cardiomyopathy.可逆性他克莫司诱导的扩张型运动功能减退性心肌病。

JACC Case Rep. 2025 Jul 30;30(21):104336. doi: 10.1016/j.jaccas.2025.104336.

2

What Causes Hypertrophic Cardiomyopathy?什么导致肥厚型心肌病？

Am J Cardiol. 2022 Sep 15;179:74-82. doi: 10.1016/j.amjcard.2022.06.017. Epub 2022 Jul 14.

3

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新

Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.